-
Purposeretroviral expression of human PCAF in mammalian cells
-
Depositing Lab
-
Sequence Information
Ordering
Item | Catalog # | Description | Quantity | Price (USD) | |
---|---|---|---|---|---|
Plasmid | 63705 | Standard format: Plasmid sent in bacteria as agar stab | 1 | $85 |
Backbone
-
Vector backbonepMSCVpuro
- Backbone size w/o insert (bp) 6300
- Total vector size (bp) 8800
-
Vector typeMammalian Expression, Retroviral
-
Selectable markersPuromycin
Growth in Bacteria
-
Bacterial Resistance(s)Ampicillin, 100 μg/mL
-
Growth Temperature37°C
-
Growth Strain(s)XL10 Gold
-
Copy numberHigh Copy
Gene/Insert
-
Gene/Insert namePCAF
-
Alt nameKAT2B
-
Alt nameP300/CBP-associated factor
-
Alt nameK(lysine) acetyltransferase 2B
-
SpeciesH. sapiens (human)
-
Insert Size (bp)2500
-
MutationE452G
-
GenBank IDBC060823 BC060823
-
Entrez GeneKAT2B (a.k.a. CAF, P/CAF, PCAF)
-
Tag
/ Fusion Protein
- None
Cloning Information
- Cloning method Restriction Enzyme
- 5′ cloning site Bgl II (not destroyed)
- 3′ cloning site Xho I (not destroyed)
- 5′ sequencing primer MSCV5
- 3′ sequencing primer MSCV3 (Common Sequencing Primers)
Resource Information
-
Supplemental Documents
-
A portion of this plasmid was derived from a plasmid made byMGC clone 71679
-
Article Citing this Plasmid
Terms and Licenses
-
Academic/Nonprofit Terms
-
Industry Terms
- Not Available to Industry
Trademarks:
- Zeocin® is an InvivoGen trademark.
Depositor Comments
Addgene QC NGS identified a E452G discrepancy in the PCAF insert relative to Genbank ID: BC060823. It is unknown what, if any, impact this may have on function.
These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.
-
For your Materials & Methods section:
pMSCVpuro-PCAF was a gift from Kai Ge (Addgene plasmid # 63705 ; http://n2t.net/addgene:63705 ; RRID:Addgene_63705) -
For your References section:
Gcn5 and PCAF negatively regulate interferon-beta production through HAT-independent inhibition of TBK1. Jin Q, Zhuang L, Lai B, Wang C, Li W, Dolan B, Lu Y, Wang Z, Zhao K, Peng W, Dent SY, Ge K. EMBO Rep. 2014 Nov;15(11):1192-201. doi: 10.15252/embr.201438990. Epub 2014 Sep 30. 10.15252/embr.201438990 PubMed 25269644